Growth Metrics

Evolus (EOLS) Liabilities and Shareholders Equity (2017 - 2026)

Evolus filings provide 10 years of Liabilities and Shareholders Equity readings, the most recent being $220.6 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 3.41% to $220.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $894.3 million, a 1.65% decrease, with the full-year FY2025 number at $225.9 million, down 2.88% from a year prior.
  • Liabilities and Shareholders Equity hit $220.6 million in Q1 2026 for Evolus, down from $225.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $233.8 million in Q2 2024 to a low of $160.2 million in Q1 2023.
  • Median Liabilities and Shareholders Equity over the past 5 years was $219.0 million (2025), compared with a mean of $207.0 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: plummeted 30.88% in 2022 and later skyrocketed 41.15% in 2024.
  • Evolus' Liabilities and Shareholders Equity stood at $178.0 million in 2022, then increased by 6.19% to $189.0 million in 2023, then rose by 23.05% to $232.6 million in 2024, then dropped by 2.88% to $225.9 million in 2025, then fell by 2.31% to $220.6 million in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $220.6 million (Q1 2026), $225.9 million (Q4 2025), and $219.0 million (Q3 2025) per Business Quant data.